Monroe, NY, United States of America

Angelo P Consalvo

USPTO Granted Patents = 21 


 

Average Co-Inventor Count = 3.2

ph-index = 9

Forward Citations = 175(Granted Patents)


Location History:

  • Monroe, NJ (US) (2001)
  • Fairfield, NJ (US) (2011)
  • Monroe, NY (US) (2000 - 2018)

Company Filing History:


Years Active: 2000-2018

Loading Chart...
Loading Chart...
Loading Chart...
21 patents (USPTO):Explore Patents

Title: **Profile of Angelo P. Consalvo: Innovator in Pharmaceutical Patents**

Introduction

Angelo P. Consalvo, based in Monroe, NY, is a prolific inventor with a remarkable track record, holding 21 patents to his name. His contributions to the field of pharmaceuticals, particularly in anti-inflammatory treatments, underscore his significant impact on medical research and innovation.

Latest Patents

Among his latest inventions, Consalvo has developed groundbreaking anti-inflammatory pharmaceutical products. Notably, his work includes polypeptides that exhibit homology to regions of the N-terminal 50 residues of human Annexin 1, which are designed for use as anti-inflammatory agents. Some of these polypeptides focus on the N-terminal 48 residues, particularly the sequences between residues 2-48 and 11-48. His patents disclose methods to enhance the properties of these compounds through specific modifications at residues corresponding to 11, 22, 25, and/or 36 of human Annexin 1, along with C-terminal amidation of the polypeptide. Furthermore, he has introduced innovative peptide pharmaceuticals intended for oral delivery. These compositions utilize acid-containing formulations that include peptide compounds, employing barrier layers to mitigate adverse interactions. This approach is believed to promote a more simultaneous release of composition components, thereby improving the bioavailability of the active peptide compounds.

Career Highlights

Angelo's professional journey includes key roles at Unigene Laboratories Inc. and Enteris Biopharma, Inc. Throughout his career, he has focused on creating therapeutic solutions aimed at addressing complex medical challenges. His inventions have the potential to change the landscape of anti-inflammatory treatments, influencing both clinical practice and pharmaceutical development.

Collaborations

In his career, Consalvo has collaborated with esteemed colleagues, including Nozer M. Mehta and Christopher P. Meenan. These partnerships have fostered a dynamic environment for innovation, allowing for the successful development and refinement of his pharmaceutical inventions.

Conclusion

Angelo P. Consalvo's contributions to pharmaceutical sciences through his patents on anti-inflammatory agents highlight his role as a leading innovator in the industry. With a commitment to enhancing medical treatments, his work continues to pave the way for future advancements in drug development and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…